Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Acid-Associated Heartburn Symptoms and Dose of Esomeprazole

ClinicalTrials.gov ID: NCT00206024

Public ClinicalTrials.gov record NCT00206024. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 13, 2026, 1:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 4-week Study to Investigate the Relationship Between Resolution of Acid-Associated Heartburn Symptoms and Dose of Esomeprazole Magnesium

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multi-center, double-blind, parallel-group, randomized, proof of concept trial to investigate the relationship between dose of esomeprazole magnesium and acid-associated heartburn symptoms during 4 weeks of treatment. The safety and tolerability of esomeprazole magnesium in doses up to 40 mg BID will also be assessed.

Study identification

NCT ID
NCT00206024
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
AstraZeneca
Industry
Enrollment
330 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2004
Primary completion
Not listed
Completion
Jun 30, 2005
Last update posted
Nov 18, 2010

2004 – 2005

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
26
Facility City State ZIP Site status
Research Site Tucson Arizona
Research Site Anaheim California
Research Site Orange California
Research Site San Diego California
Research Site Washington D.C. District of Columbia
Research Site DeLand Florida
Research Site Miami Florida
Research Site New Smyrna Beach Florida
Research Site Tampa Florida
Research Site Zephyrhills Florida
Research Site Atlanta Georgia
Research Site Chicago Illinois
Research Site New Orleans Louisiana
Research Site Annapolis Maryland
Research Site Baltimore Maryland
Research Site Hollywood Maryland
Research Site Attleboro Massachusetts
Research Site Hackensack New Jersey
Research Site Vineland New Jersey
Research Site Rochester New York
Research Site Asheville North Carolina
Research Site Elkin North Carolina
Research Site Guthrie Oklahoma
Research Site Philadelphia Pennsylvania
Research Site Knoxville Tennessee
Research Site Christiansburg Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00206024, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2010 · Synced Sep 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00206024 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →